Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma

scientific article

Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2353/AJPATH.2010.091103
P932PMC publication ID2966793
P698PubMed publication ID20952593
P5875ResearchGate publication ID47449871

P50authorNoel De MirandaQ42825686
Dave S. HoonQ47357507
Rob TollenaarQ77085802
Hans MorreauQ77086752
P2093author name stringCornelis J H van de Velde
Norihiko Narita
Roderick R Turner
Michiel F G de Maat
Anne Benard
Christine Kuo
Tetsunori Yoshimura
P2860cites workEpigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?Q22251049
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityQ24618618
CpG island methylator phenotype in colorectal cancerQ24672170
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803Q27851532
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancerQ28308193
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' studyQ28348036
Epigenetics in cancerQ29547853
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerQ29614277
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaQ29615026
Three DNA methylation epigenotypes in human colorectal cancerQ33520394
Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans.Q34138105
Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase.Q34396042
Emerging pathways in colorectal-cancer developmentQ34571633
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotypeQ34975498
Methylation patterns define two types of hyperplastic polyp associated with colorectal cancerQ35596441
CpG island methylation in aberrant crypt foci of the colorectumQ35748049
Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumorsQ35748966
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studiesQ35760749
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical marginsQ35769170
Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancersQ35790190
Frequent CpG island methylation in serrated adenomas of the colorectumQ35791305
Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers.Q36213486
Serrated adenoma of the colorectum and the DNA-methylator phenotypeQ36244424
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.Q36276940
Epigenetic changes in cancer and preneoplasiaQ36547744
When does MMR loss occur during HNPCC progression?Q36693761
Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancerQ36891683
Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.Q36906164
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancerQ37185561
CpG island methylator phenotype predicts progression of malignant melanomaQ37245444
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapyQ37286893
Sensitive and specific KRAS somatic mutation analysis on whole-genome amplified DNA from archival tissuesQ38418916
Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated allelesQ38432389
Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation.Q38437756
High incidence of microsatellite instability in colorectal cancer from African Americans.Q38453072
Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriersQ39994336
Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patientsQ40082103
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.Q40582817
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplificationQ40951949
Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.Q42633182
Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 casesQ43735744
Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancerQ43824686
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cellsQ45309109
Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer.Q46121063
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancerQ46578998
Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancerQ47209748
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instabilityQ47704165
Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanomaQ47937033
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.Q51597972
Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.Q53373414
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.Q53390493
Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps.Q53632573
DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients.Q54479306
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.Q54572656
Quantitative Analysis of Methylation of Genomic Loci in Early-Stage Rectal Cancer Predicts Distant RecurrenceQ62628589
Aberrant methylation in gastric cancer associated with the CpG island methylator phenotypeQ73163014
Association between CpG island methylation and microsatellite instability in colorectal cancerQ73622839
Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancerQ78469514
Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregationQ81223357
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinomaQ81383354
CpG island methylation in aberrant crypt foci and cancers from the same patientsQ81387438
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancerQ81523798
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectmicrosatelliteQ265193
hypermethylationQ106875739
P304page(s)2347-2356
P577publication date2010-10-15
P1433published inThe American Journal of PathologyQ4744259
P1476titleDevelopment of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma
P478volume177